Cardinal Health (CAH) Receives Price Target

Cardinal Health (CAH) : The most positive equity analysts on Cardinal Health (CAH) expects the shares to touch $111, whereas, the least positive believes that the stock will trade at $89 in the short term. The company is covered by 10 Wall Street Brokerage Firms. The average price target for shares are $95.7 with an expected fluctuation of $6.82 from the mean.

Cardinal Health (CAH) has an average broker rating of 1.91, which is interpreted as a Buy, as rated by 11 equity analysts. Nonetheless, 6 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 5 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold.


Also, Equity Analysts at the Brokerage Firm, Deutsche Bank, maintains their rating on the shares of Cardinal Health (NYSE:CAH). Deutsche Bank has a Hold rating on the shares. As per the latest research report, the brokerage house raises the price target to $89 per share from a prior target of $83. The rating by the firm was issued on August 4, 2016.

Cardinal Health (NYSE:CAH): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $79.90 and $79.16 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $80.08. The buying momentum continued till the end and the stock did not give up its gains. It closed at $79.70, notching a gain of 0.04% for the day. The total traded volume was 1,638,044 . The stock had closed at $79.67 on the previous day.

Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.